Tessera Therapeutics
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Gene Writing holds the potential to become a new category in genetic medicine, building upon recent breakthroughs in gene therapy and gene editing while eliminating important limitations in their reach, utilization, and efficacy. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.
Domain
tesseratherapeutics.com
Country
United StatesIndustry
BiopharmaEmployees
251-500
Last Funding
$150.0M
Founded
2017
Tech Stack (12 technologies)
Frequently Asked Questions
What technologies does Tessera Therapeutics use?+
Tessera Therapeutics uses 12 technologies including Google Analytics, Google Tag Manager, core-js.
What industry is Tessera Therapeutics in?+
Tessera Therapeutics operates in the Biopharma industry.
Where is Tessera Therapeutics based?+
Tessera Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026